🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety of supplemental REACT i...
Status
Terminated
Location
Boise kidney and Hypertension Institute
Start Date
2023-07-11
Trial ID
NCT05694169
Treatments Being Tested
A phase 1, open-label safety, tolerability and early efficacy study of a Re...
Status
Completed
Location
Emory University Hospital
Start Date
2019-08-13
Trial ID
NCT04115345
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy (including d...
Status
Withdrawn
Location
IMIM Hospital del Mar Medical Research Institute
Start Date
2024-07-17
Trial ID
NCT05286853
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of up to 2 R...
Status
Active Not Recruiting
Location
Nephrology Consultants
Start Date
2022-01-05
Trial ID
NCT05099770
Treatments Being Tested
The purpose of the present study is to assess the safety and efficacy of up...
Status
Completed
Location
University of Arizona [WITHDRAWN]
Start Date
2018-04-25
Trial ID
NCT03270956
Treatments Being Tested
To assess the safety and efficacy of up to two REACT injections given 6 mon...
Status
Completed
Location
University of Arizona
Start Date
2016-09
Trial ID
NCT02836574
Treatments Being Tested
The purpose of this study is to assess the safety, efficacy, and durability...
Status
Completed
Location
Kidney Associates of Colorado, P.C. - Frenova
Start Date
2021-07-27
Trial ID
NCT05018416
Treatments Being Tested
The purpose of this study is to evaluate the long-term safety of up to two ...
Status
Recruiting
Location
Boise Kidney & Hypertension Institute
Start Date
2023-12-11
Trial ID
NCT05918523
Treatments Being Tested
The purpose of this study is to evaluate the long-term safety, efficacy, an...
Status
Enrolling By Invitation
Location
Boise Kidney & Hypertension Institute
Start Date
2023-11-23
Trial ID
NCT06790498
Treatments Being Tested